564
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

A neonatal gnotobiotic pig model of human enterovirus 71 infection and associated immune responses

, , , , , , , , , , , , & show all
Pages 1-12 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T.Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol2010;9: 1097–1105.
  • Zeng M, El Khatib NF, Tu S et al.Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol2012;53: 285–289.
  • Ho M, Chen ER, Hsu KH et al.An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med1999;341: 929–935.
  • Xing W, Liao Q, Viboud C et al.Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis2014;14: 308–318.
  • Hashimoto I, Hagiwara A.Studies on the pathogenesis of and propagation of enterovirus 71 in Poliomyelitis-like disease in monkeys. Acta Neuropathol1982;58: 125–132.
  • Hashimoto I, Hagiwara A, Kodama H.Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease. Arch Virol1978;56: 257–261.
  • Arita M, Shimizu H, Nagata N et al.Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol2005;86: 1391–1401.
  • Dong C, Liu L, Zhao H et al.Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine2011;29: 6269–6275.
  • Lin YL, Yu CI, Hu YC et al.Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine2012;30: 1305–1312.
  • Nie K, Zhang Y, Luo L et al.Visual detection of human enterovirus 71 subgenotype C4 and Coxsackievirus A16 by reverse transcription loop-mediated isothermal amplification with the hydroxynaphthol blue dye. J Virol Methods2011;175: 283–286.
  • Wang YF, Chou CT, Lei HY et al.A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol2004;78: 7916–7924.
  • Khong WX, Yan B, Yeo H et al.A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol2012;86: 2121–2131.
  • Liu J, Dong W, Quan X et al.Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol2012;157: 539–543.
  • Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V.The pig: a model for human infectious diseases. Trends Microbiol2012;20: 50–57.
  • Ward LA, Rosen BI, Yuan L, Saif LJ.Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol1996;77: 1431–1441.
  • Yuan L, Wen K, Azevedo MS et al.Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs. Vaccine2008;26: 3322–3331.
  • Yuan L, Saif LJ.Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet Immunol Immunopathol2002;87: 147–160.
  • Wen K, Li G, Bui T et al.High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine2012;30: 1198–1207.
  • Souza M, Costantini V, Azevedo MS, Saif LJ.A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model. Vaccine2007;25: 8448–8459.
  • Nishimura Y, Shimojima M, Tano Y et al.Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med2009;15: 794–797.
  • Yamayoshi S, Yamashita Y, Li J et al.Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med2009;15: 798–801.
  • Yang B, Chuang H, Yang KD.Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J2009;6: 141.
  • Baisse B, Galisson F, Giraud S, Schapira M, Spertini O.Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function. BMC Evol Biol2007;7: 166.
  • Kim JW, Zhao SH, Uthe JJ, Bearson SM, Tuggle CK.Assignment of the scavenger receptor class B, member 2 gene (SCARB2) to porcine chromosome 8q11-->q12 by somatic cell and radiation hybrid panel mapping. Cytogenet Genome Res2006;112: 342H.
  • Liu F, Li G, Wen K et al.Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics. Viral Immunol2010;23: 135–149.
  • Yuan L, Ward LA, Rosen BI, To TL, Saif LJ.Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol1996;70: 3075–3083.
  • Tan EL, Yong LL, Quak SH et al.Rapid detection of enterovirus 71 by real-time TaqMan RT-PCR. J Clin Virol2008;42: 203–206.
  • Meyer RC, Bohl EH, Kohler EM.Procurement and maintenance of germ-free seine for microbiological investigations. Appl Microbiol1964;12: 295–300.
  • Yuan L, Ishida S, Honma S et al.Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines. J Infect Dis2004;189: 1833–1845.
  • Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG.Crystal structure of human enterovirus 71. Science2012;336: 1274.
  • Wang X, Peng W, Ren J et al.A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol2012;19: 424–429.
  • Solomon T, Lewthwaite P, Perera D et al.Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis2010;10: 778–790.
  • Weng KF, Chen LL, Huang PN, Shih SR.Neural pathogenesis of enterovirus 71 infection. Microbes Infect2010;12: 505–510.
  • Wang SM, Lei HY, Huang KJ et al.Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis2003;188: 564–570.
  • Wong KT, Munisamy B, Ong KC et al.The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol2008;67: 162–169.
  • Wen YY, Chang TY, Chen ST, Li C, Liu HS.Comparative study of enterovirus 71 infection of human cell lines. J Med Virol2003;70: 109–118.
  • Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY.Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis2003;36: 269–274.
  • Chang LY, Tsao KC, Hsia SH et al.Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA2004;291: 222–227.
  • Cerf-Bensussan N, Gaboriau-Routhiau V.The immune system and the gut microbiota: friends or foes? Nat Rev Immunol2010;10: 735–744.
  • Hsueh C, Jung SM, Shih SR et al.Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod Pathol2000;13: 1200–1205.
  • Zhang Y, Cui W, Liu L et al.Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab Invest2011;91: 1337–1350.
  • Chang LY, Hsiung CA, Lu CY et al.Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res2006;60: 466–471.
  • Wang SM, Lei HY, Su LY et al.Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. Clin Microbiol Infect2007;13: 677–682.
  • Yang C, Deng C, Wan J, Zhu L, Leng Q.Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol J2011;8: 306.
  • Zhu FC, Wang JZ, Li XL et al.Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants. Pediatr Infect Dis J2012;31: 1158–1165.
  • Li YP, Liang ZL, Gao Q et al.Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine2012;30: 3295–3303.
  • Yan XF, Gao S, Xia JF et al.Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis2012;44: 297–305.
  • Wang W, Duo J, Liu J et al.A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect2011;13: 862–870.